| 发明名称 |
ЛЕЧЕНИЕ ИЛИ ПРОФИЛАКТИКА ОТТОРЖЕНИЯ ИНСУЛИН-ПРОДУЦИРУЮЩЕГО КЛЕТОЧНОГО ТРАНСПЛАНТАТА |
| 摘要 |
A pharmaceutical combination comprising an accelerated lymphocyte homing agent in free form or in pharmaceutically acceptable salt form, and one or more compounds selected from the group consisting of an antibody to the IL-2 receptor, an immunosuppressive macrocyclic lactone and a soluble human complement inhibitor is used to treat or prevent insulin-producing cell graft rejection. |
| 申请公布号 |
RU2003136730(A) |
申请公布日期 |
2005.05.20 |
| 申请号 |
RU20030136730 |
申请日期 |
2002.06.07 |
| 申请人 |
НОВАРТИС АГ (CH) |
发明人 |
ЛЕЙК Филип (US);МАЛЛОН Клоди (US) |
| 分类号 |
A61K45/00;A61K31/137;A61K31/436;A61K38/00;A61K39/00;A61K39/395;A61K45/06;A61P3/10;A61P37/06;C07K16/28 |
主分类号 |
A61K45/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
